COMMUNIQUÉS West-GlobeNewswire

New Opportunity Navigator™ Predictive Analytics Solution Refined Through Vital Images® and Fairview Collaboration
05/03/2018
Solution provides next-generation analytics with predictive capabilities MINNETONKA, Minn., March 05, 2018 (GLOBE NEWSWIRE) -- Vital Images announced today it refined its latest innovation, Vitrea ® Intelligence [...]
Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners
05/03/2018
BOULDER, Colo., March 05, 2018 (GLOBE NEWSWIRE) -- Biodesix, Inc., a molecular diagnostics company that develops and commercializes non-invasive, blood-based diagnostic tests for oncology, today announced that the [...]
Notification about capital shares
05/03/2018
Latvia, 2018-03-05 18:52 CET (GLOBE NEWSWIRE) -- AS ”Latvijas Jūras medicīnas centrs” informs it has sold 50.4% from share capital SIA “Klīnika Dzintari”. The deal is finished on 23 February, 2018. and AS ”Latvijas [...]
GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March
05/03/2018
LONDON and CARLSBAD, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH ) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Healthwise and Mytonomy Partner to Deliver Health Education Videos
05/03/2018
BOISE, Idaho, March 05, 2018 (GLOBE NEWSWIRE) -- Healthwise and Mytonomy announced today that they will partner in offering patient instructions and health education videos to health care providers and their patients. [...]
Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018
05/03/2018
PHILADELPHIA and OXFORD, United Kingdom, March 05, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, will announce financial results for the Fourth [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018
05/03/2018
Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018
05/03/2018
Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]
VALNEVA : Déclaration d'actions et de droits de vote - février 2018
05/03/2018
VALNEVA Déclaration d'actions et de droits de vote - FEVRIER 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Shire plc : Director/PDMR Shareholding
05/03/2018
Director/PDMR Shareholding March 5, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by person discharging managerial responsibilities 1. Details of the person discharging managerial [...]
Asthma Adherence Management Findings Utilizing Adherium’s Smartinhaler™ Technology Presented at AAAAI/WAO
05/03/2018
SAN MATEO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), announced the presentation of new study results utilizing the Smartinhaler TM technology at the Joint Congress of the American Academy of Allergy [...]
Ossur Hf : Össur hf. initiates a new share buyback program
05/03/2018
Announcement from Össur hf. No. 16/2018 Reykjavík, 5 March 2018 Össur hf. has decided to initiate a new share buyback program (the "Program") tomorrow, 6 March 2018, which will replace the share buyback program that was [...]
Ossur Hf : Share buyback program completed
05/03/2018
Announcement from Össur hf. No. 15/2018 Reykjavík, 5 March 2018 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program was to [...]
Shire plc : U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
05/03/2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and deep [...]
The Alliance for Regenerative Medicine Releases 2017 Annual Data Report, Highlighting Sector Trends and Metrics
05/03/2018
WASHINGTON, D.C., March 05, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2017 Annual Data Report, offering an in-depth look at trends and metrics for the cell [...]
Tetra Bio-Pharma Announces Closing of Bought Deal Financing
05/03/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES OTTAWA, March 05, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Corporation ”) (TSX-V: TBP ) (OTCQB: [...]
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
05/03/2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation NDA acceptance of prucalopride reinforces Shire's long-standing heritage in gastrointestinal (GI) conditions and deep [...]
Celsion Announces Ovarian Cancer Expert Presentation at Oppenheimer & Co. Investor Event
05/03/2018
LAWRENCEVILLE, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) today announced that Premal H. Thaker, M.D., M.S., Associate Professor of Obstetrics and Gynecology at the Siteman Cancer Center [...]
Transactions under Novozymes’ stock buyback program
05/03/2018
Please read the full announcement in the attached PDF 2018_06_Stock_Buybackprogram_EN

Pages